Stay updated on Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.

Latest updates to the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a small update to the page rather than a substantive change to the study details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThis update changes the displayed platform revision identifier from v3.5.2 to v3.5.3 on the page, reflecting an internal site/version update rather than a change to the clinical study information.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a minor software version upgrade with no visible content changes.SummaryDifference0.0%

- Check72 days agoChange DetectedThe revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.0%

- Check108 days agoChange DetectedThe page revision tag was updated to v3.4.2, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.